Abstract
Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care.
| Original language | English |
|---|---|
| Pages (from-to) | 233-235 |
| Number of pages | 3 |
| Journal | Journal of Pediatrics |
| Volume | 134 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1999 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Fingerprint
Dive into the research topics of 'Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver